Concepedia

Author

Wangjun Liao

Nanfang HospitalORCID

Also Known As

Dong Wang, Guojun Chen, Jingtang Chen, Liao, Wangjun, Min Shi, Tao Zhang, W Liao, W. Liao, WANGJUN LIAO, Wang-Jun Liao

372

Publications

14.8K

Citations

61

H-Index

119

Concepts

All Affiliations

Nanfang HospitalSouthern Medical UniversityGuangzhou Medical UniversitySun Yat-sen UniversityChinese Academy of Medical Sciences & Peking Union Medical College
WL

About

Wangjun Liao is an author at Nanfang Hospital specializing in medicine, tumor biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

44

3.9K

2

Engineering

9

9

636

3

Health Sciences

6

6

480

4

Public Health

1

1

10

5

Biochemistry

1

1

48

Wangjun Liao

×

158

Publications

13.4K

Citations

58

H-Index

YearCitations

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures

Dongqiang Zeng, Zilan Ye, Rongfang Shen,

Frontiers in Immunology

2021

1.2K

Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures

Dongqiang Zeng, Meiyi Li, Rui Zhou,

Cancer Immunology Research

2019

1.1K

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao,

Cancer Cell

2022

523

Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice

Senlin Huang, Xinzhong Li, Hao Zheng,

Circulation

2019

453

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen,

Nature Medicine

2021

387

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Feng‐Hua Wang, Xiaoli Wei, Jifeng Feng,

Journal of Clinical Oncology

2021

336

MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer

Wanming He, Bishan Liang, Chunlin Wang,

Oncogene

2019

316

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer

Rui Zhou, Jingwen Zhang, Dongqiang Zeng,

Cancer Immunology Immunotherapy

2018

297

Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells

Shihui Hao, Yu Jiang, Wanming He,

Neoplasia

2017

295

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Shun Lü, Jie Wang, Yan Yu,

Journal of Thoracic Oncology

2021

264

Page 1